US Patent 8648041 Double-acylated GLP-1 derivatives
Patent 8648041 was granted and assigned to Novo Nordisk on February, 2014 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8648041 Double-acylated GLP-1 derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
